scholarly journals Measurement of bone mineral density as an efficacy marker in denosumab treatment of giant cell tumour of bone

2017 ◽  
pp. bcr-2017-220369 ◽  
Author(s):  
Christian Veng ◽  
Peter Holmberg Jørgensen ◽  
Inger Krog-Mikkelsen ◽  
Maiken Stilling
Keyword(s):  
Bone Mineral Density ◽  
Giant Cell ◽  
Bone Mineral ◽  
Giant Cell Tumour ◽  
Cell Tumour ◽  
Mineral Density ◽  
Denosumab Treatment

scholarly journals Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab

2018 ◽  
pp. bcr-2018-225095
Author(s):  
Duarte Rosa ◽  
Raquel Baptista Dias ◽  
João Cunha Salvador ◽  
Alexandra Borges
Keyword(s):  
Maxillary Sinus ◽  
Giant Cell ◽  
Giant Cell Tumour ◽  
Neck Surgery ◽  
Cell Tumour ◽  
Pterygoid Process ◽  
Bone Expansion ◽  
The Right ◽  
Denosumab Treatment

We report the case of a 74-year-old man with a giant cell tumour (GCT) of the right maxilla and pterygoid process. The patient presented to the maxillofacial and head and neck surgery clinic with an ulcerated lesion of the hard palate. Initial workup with CT revealed a mass within the right maxillary sinus and pterygoid process with associated bone expansion and erosion. Biopsy showed a GCT with mucosal ulceration. Two years after surgical resection, a follow-up CT revealed tumour recurrence involving the right pterygoid process and lateral pterygoid muscle. The patient was then proposed for therapy with denosumab. Under denosumab treatment, the lesion maintained stable dimensions and became sclerotic and heavily ossified.

scholarly journals Relationship Between Bone Mineral Density T ‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment

2019 ◽  
Vol 34 (6) ◽  
pp. 1033-1040 ◽  
Author(s):  
S Ferrari ◽  
C Libanati ◽  
Celia Jow Fang Lin ◽  
JP Brown ◽  
F Cosman ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Fracture Risk ◽  
Bone Mineral ◽  
Nonvertebral Fracture ◽  
Mineral Density ◽  
T Score ◽  
Denosumab Treatment

scholarly journals Hip fractures following denosumab discontinuation: three clinical cases reports

2019 ◽  
Vol 112 (11) ◽  
pp. 472-475 ◽  
Author(s):  
Manuel Sosa Henríquez ◽  
María Jesús Gómez de Tejada Romero ◽  
María Escudero-Socorro ◽  
Oscar Torregrosa Suau
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Hip Fractures ◽  
Vertebral Fractures ◽  
Femoral Fractures ◽  
Significant Loss ◽  
Mineral Density ◽  
Denosumab Treatment ◽  
Multiple Vertebral Fractures ◽  
Clinical Cases

Summary A significant loss of bone mineral density and the appearance of multiple vertebral fractures after discontinuation of denosumab treatment have been described. To date, no hip fractures have been reported. We present three cases of patients who suffered femoral fractures after denosumab suppression.

scholarly journals Combining two-stage surgery and denosumab treatment in a patient with giant cell tumour of the lumbar spine with intraperitoneal growth

2018 ◽  
Vol 95 (1120) ◽  
pp. 106-107 ◽  
Author(s):  
Shuzhong Liu ◽  
Xi Zhou ◽  
An Song ◽  
Zhen Huo ◽  
Yipeng Wang ◽  
...  
Keyword(s):  
Lumbar Spine ◽  
Giant Cell ◽  
Giant Cell Tumour ◽  
Cell Tumour ◽  
Two Stage ◽  
Denosumab Treatment

Effects of denosumab treatment on bone mineral density and joint destruction in patients with rheumatoid arthritis

2017 ◽  
Vol 36 (4) ◽  
pp. 431-438 ◽  
Author(s):  
Takeshi Mochizuki ◽  
Koichiro Yano ◽  
Katsunori Ikari ◽  
Kosei Kawakami ◽  
Ryo Hiroshima ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Bone Mineral Density ◽  
Bone Mineral ◽  
Joint Destruction ◽  
Mineral Density ◽  
Denosumab Treatment
Sign in / Sign up

Export Citation Format

Share Document